v3.25.1
Condensed Consolidated Statements of Operation - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue    
Total revenue $ 16,532 $ 12,947
Cost of revenue 1,526 1,468
Gross profit 15,006 11,479
Operating expenses:    
Research and development 11,862 10,835
Sales and marketing 6,529 5,456
General and administrative 4,323 4,322
Total operating expenses 22,714 20,613
Loss from operations (7,708) (9,134)
Interest expense (48) (76)
Other income (expense), net 718 936
Loss before income taxes and loss from equity method investment (7,038) (8,274)
Loss from equity method investment, net of tax 815 759
Provision for income taxes 268 370
Net loss $ (8,121) $ (9,403)
Net loss per share attributable to common stockholders    
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.20) $ (0.25)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.20) $ (0.25)
Weighted average shares used in computing per share amounts    
Weighted average shares used in computing per share amounts, basic (in shares) 40,853,048 37,709,058
Weighted average shares used in computing per share amounts, basic (in shares) 40,853,048 37,709,058
Licensing, support and maintenance    
Revenue    
Total revenue $ 15,335 $ 11,739
Variable royalties and other    
Revenue    
Total revenue $ 1,197 $ 1,208